Ufrim Side Effects

Ufrim is commonly used to treat depression and anxiety disorders. While many people tolerate Ufrim well, some individuals may experience common and less common side effects. Here are some common and less common side effects of Ufrim.

Common Side Effects

• Nausea: Feeling nauseous or having an upset stomach is a common side effect associated with Ufrim, especially during the initial days of treatment.
• Insomnia or sleep disturbances: Some people may experience difficulty falling asleep, staying asleep, or changes in sleep patterns with Ufrim.
• Fatigue: Feeling tired or having low energy levels is a common side effect of Ufrim.
• Drowsiness: Ufrim can cause drowsiness in some individuals, particularly when starting the medication or when the dosage is increased.
• Dry mouth: A dry, uncomfortable feeling in the mouth may occur while taking Ufrim.
• Increased sweating: Some people may notice an increase in sweating, especially during sleep.
• Weight changes: Both weight gain and weight loss have been reported as side effects, though the impact on weight is generally considered modest.
• Sexual side effects: This may include changes in libido, difficulty achieving or maintaining an erection (erectile dysfunction), or difficulty reaching orgasm.
• Gastrointestinal issues: Diarrhea or constipation may occur in some individuals while taking Ufrim.
• Headache: Headaches are a common side effect, particularly early in the course of treatment of Ufrim.

Less Common Side Effects

• Allergic reactions: In rare cases, individuals may experience an allergic reaction to Ufrim, which can manifest as skin rash, itching, swelling, severe dizziness, or difficulty breathing. Seek immediate medical attention if you suspect an allergic reaction.
• Suicidal thoughts or behaviors: Though uncommon, certain individuals, especially adolescents and young adults, may experience an increase in suicidal thoughts or behaviors when starting Ufrim.
• Serotonin syndrome: This is a potentially life-threatening condition that can occur when there is an excess of serotonin in the body. Symptoms may include agitation, hallucinations, rapid heartbeat, fever, muscle stiffness, and loss of coordination.
• Abnormal bleeding: Ufrim may increase the risk of bleeding, especially when taken with other medications that affect blood clotting.
• Hyponatremia (low sodium levels): In rare cases, Ufrim has been associated with the development of low sodium levels in the blood, which can lead to symptoms such as headache, difficulty concentrating, memory changes, confusion, weakness, and unsteadiness.
• Manic episodes: In individuals with a history of bipolar disorder, treatment with Ufrim may precipitate a manic episode.
• Seizures: While seizures are rare, they have been reported in some individuals taking Ufrim.

Ufrim is one of the leading brands of Escitalopram, manufactured and marketed by High Q Pharmaceuticals, Pakistan.

Presently, Ufrim is available in Tablet Form.

Ufrim Tablet : 10mg strength.

1. Monoamine Oxidase Inhibitors (MAOIs): Concurrent use of Ufrim with MAOIs or within 14 days of stopping an MAOI may increase the risk of serotonin syndrome, a potentially life-threatening condition.
2. Serotonergic Medications: Combining Ufrim with other serotonergic medications, such as other SSRIs, SNRIs, or triptans, may increase the risk of serotonin syndrome.
3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Anticoagulants: Ufrim may increase the risk of bleeding when taken with NSAIDs or anticoagulants.
4. Warfarin: Ufrim may increase the effects of warfarin, an anticoagulant.
5. Cimetidine: Cimetidine, a medication used for stomach acid reduction, may increase Ufrim levels in the blood.
6. Triptans (e.g., sumatriptan): Combining Ufrim with triptans may increase the risk of serotonin syndrome.
7. Lithium: Ufrim may increase lithium levels in the blood, potentially leading to toxicity.
8. Buspirone: Combining buspirone with Ufrim may increase the risk of serotonin syndrome.
9. QT Prolonging Drugs (e.g., certain antipsychotics, antiarrhythmics): Ufrim may increase the risk of QT interval prolongation when used with drugs that also have this effect.